Business
Ventripoint Exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session
(TheNewswire) Toronto, Ontario – TheNewswire – June 7, 2022 ...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Toronto, Ontario – TheNewswire –\nJune 7, 2022\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF) is pleased to announce that it will be exhibiting\nand attending as a sponsor (\n \n \n \n \n https://www.asescientificsessions.org/sponsors/\n \n \n \n \n ) of the American Society of Echocardiography (ASE) 2022\nConference titled “Sound Waves in Seattle: Connecting the World”.\nThis is the 33\n \n \n rd\n \n \n annual scientific session of the ASE and is\nbeing held in the Seattle Convention Center June 10-13, 2022.\n \n \n \n \n The ASE is an organization (\n \n \n \n \n https://www.asecho.org/about-ase/\n \n \n \n \n ) comprised of members of the cardiac field who work to\nadvance cardiovascular ultrasound and strive to promote education,\nresearch, innovation, and service to the profession and public. This\nyear’s scientific session will be bringing in thousands of attendees\nfrom the cardiovascular profession.\n \n \n \n \n Ventripoint will be one of the sponsors for the 2022\nevent and will have the opportunity to engage with thousands of\nattendees though networking sessions, an in-person and virtual\nexhibit, poster presentations, and hands on educational workshops.\n \n \n \n \n Ventripoint joining ASE 2022 through their sponsorship\nopportunities will highlight the VMS+ and its new developments, engage\nwith new customers, and establish stronger relationships with existing\ncustomers.\n \n \n \n \n About Ventripoint Diagnostics\nLtd.\n \n \n \n \n Ventripoint\n \n \n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS products are powered by its\nproprietary KBR technology, which is the result of a decade of\ndevelopment and provides accurate volumetric cardiac measurements\nequivalent to MRI. This affordable, gold-standard alternative allows\ncardiologists greater confidence in the management of their patients.\nProviding better care to patients serves as a springboard and basic\nstandard for all of Ventripoint's products that guide our future\ndevelopmen...